Amy S. Paller, MD, FAAD
SESSIONS
No sessions scheduled for this speaker.
DISCLOSURES
AbbVie – Consultant(Honoraria); Abeona Therapeutics – Consultant(Honoraria); Aegerion Pharma – Consultant (1099 relationship)(Honoraria); Aegerion Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Azitra, Inc – Consultant(Honoraria); BioCryst Pharmaceuticals, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Consultant(Honoraria); Bristol-Myers Squibb – Consultant(Honoraria); Castle Creek Pharmaceuticals – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Catawba Research, LLC – Consultant(Honoraria); Dermavant Sciences, Inc. – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant(Honoraria), Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Consultant(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); InMed Pharmaceuticals, Inc – Consultant(Honoraria); Janssen Research & Development, LLC – Investigator(Grants/Research Funding); Johnson & Johnson Pharmaceutical Research & Development – Consultant (1099 relationship)(Honoraria); Krystal Biotech, Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Honoraria); Novartis Pharmaceuticals Corp. – Consultant(Honoraria); Regeneron – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi Genzyme – Consultant(Honoraria); TWi Biotechnology, Inc. – Advisory Board(Honoraria); UCB – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding);